Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2004

01-08-2004 | Commentary

What should be the core outcomes in chronic pain clinical trials?

Authors: Dennis C Turk, Robert H Dworkin

Published in: Arthritis Research & Therapy | Issue 4/2004

Login to get access

Abstract

A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted.
Literature
1.
go back to reference Abbott FV, Fraser MI: Use and abuse of over-the-counter analgesic agents. J Psychiat Neurosci. 1998, 23: 13-34. Abbott FV, Fraser MI: Use and abuse of over-the-counter analgesic agents. J Psychiat Neurosci. 1998, 23: 13-34.
2.
go back to reference Pleis JR, Coles R: Summary health statistics for U.S. adults: National Health Interview Survey, 1998. 2002, National Center for Health Statistics, Vital Health Statistics, 10 (209): Pleis JR, Coles R: Summary health statistics for U.S. adults: National Health Interview Survey, 1998. 2002, National Center for Health Statistics, Vital Health Statistics, 10 (209):
3.
go back to reference United States Bureau of the Census: Statistical Abstract of the United States: 1996. 1996, Washington DC: US Bureau of the Census, 116 United States Bureau of the Census: Statistical Abstract of the United States: 1996. 1996, Washington DC: US Bureau of the Census, 116
4.
go back to reference National Research Council: Musculoskeletal disorders and the workplace. 2001, Washington DC: National Academy Press National Research Council: Musculoskeletal disorders and the workplace. 2001, Washington DC: National Academy Press
5.
go back to reference Deyo RA, Battie M, Beurskens AHHM, Bombardier C, Croft P, Koes B: Outcome measures for low back pain research. A proposal for standardized use. Spine. 1998, 23: 2003-2013. 10.1097/00007632-199809150-00018.CrossRefPubMed Deyo RA, Battie M, Beurskens AHHM, Bombardier C, Croft P, Koes B: Outcome measures for low back pain research. A proposal for standardized use. Spine. 1998, 23: 2003-2013. 10.1097/00007632-199809150-00018.CrossRefPubMed
6.
go back to reference Revicki DA: Health care technology assessment and health-related quality of life. In Health Care Technology and Its Assessment: An International Perspective. Edited by: Banta D, Luce BR. 1993, New York: Oxford University Press, 114-131. Revicki DA: Health care technology assessment and health-related quality of life. In Health Care Technology and Its Assessment: An International Perspective. Edited by: Banta D, Luce BR. 1993, New York: Oxford University Press, 114-131.
7.
go back to reference Waddell G: The back pain revolution. 1998, London: Churchill Livingstone Waddell G: The back pain revolution. 1998, London: Churchill Livingstone
8.
go back to reference Anderson RB, Hollenberg NK, Williams GH: Physical Symptoms Distress Index. A sensitive tool to evaluate the impact of pharmacological agents. Arch Intern Med. 1999, 159: 693-700. 10.1001/archinte.159.7.693.CrossRefPubMed Anderson RB, Hollenberg NK, Williams GH: Physical Symptoms Distress Index. A sensitive tool to evaluate the impact of pharmacological agents. Arch Intern Med. 1999, 159: 693-700. 10.1001/archinte.159.7.693.CrossRefPubMed
9.
go back to reference Anderson RB, Testa MA: Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inform J. 1994, 28: 89-114. Anderson RB, Testa MA: Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inform J. 1994, 28: 89-114.
10.
go back to reference Moher D, Schulz K, Altman DG, for the CONSORT Group: The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001, 134: 657-662.CrossRefPubMed Moher D, Schulz K, Altman DG, for the CONSORT Group: The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001, 134: 657-662.CrossRefPubMed
11.
go back to reference Bellamy N, Kirwan J, Boers M: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997, 24: 799-802.PubMed Bellamy N, Kirwan J, Boers M: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997, 24: 799-802.PubMed
Metadata
Title
What should be the core outcomes in chronic pain clinical trials?
Authors
Dennis C Turk
Robert H Dworkin
Publication date
01-08-2004
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2004
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1196

Other articles of this Issue 4/2004

Arthritis Research & Therapy 4/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.